In focus
Latest feed
Amneal’s Generic Lanreotide Wins FDA Clearance, Shares Surge
Hansa Biopharma Illuminates a Path Forward: Unpacking the Vision from Their Capital Markets Day
Ultragenyx’s Rare‑Disease Stock Soars After FDA Greenlights First Sanfilippo Gene Therapy
FDA Greenlights First‑In‑Class Glioma Imaging Drug Pixclara
